María Sonsoles de Icaza y de León, marquesa de Llanzol (Ávila, ... - dofaq.co
María Sonsoles de Icaza y de León , marquesa de Llanzol (Ávila, ...María Sonsoles de Icaza y de León , marquesa de Llanzol (Ávila, 13 de agosto de 1914-Madrid, 21 de enero de 1996) fue una aristócrata española, musa del diseñador Cristóbal Balenciaga. Su padre fue el escritor y embajador mexicano Francisco A. de Icaza, su hermana la escritora Carmen de Icaza y una de sus hijas, Carmen Díez de Rivera, fue conocida por su actividad política.
Neurona Therapeutics Presents Positive Clinical Update from NRTX-1001 Cell Therapy Trial in Adults with Drug ...
Neurona Raises $120M, Buoyed by Early-Stage Data for Epilepsy Cell Therapy
Neurona knocks out $120M raise a year after layoffs
Wilson Sonsini Advises Neurona Therapeutics on $120 Million Financing
Neurona secures $120m to advance lead cell therapy candidate for epilepsy - PharmaTimes
Neurona's brain stem cell therapy shows early efficacy in epilepsy
Neurona Therapeutics Raises $120M in Funding
Venture report: Scion's launch, rounds for Neurona, Attralus and Basking
Improved Understanding of the Genome of S. neurona neurona ...
The same genotype of Sarcocystis neurona responsible for mass mortality in marine mammals induced a clinical ... neurona responsible for mass mortality in marine mammals induced a clinical ... ...
Biotech Co. Neurona Therapeutics Raises $120M
Epilepsy-focused cell therapy biotech lands $120 million for potential 'game-changer' - San Francisco Business Times
Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates ...
Neurona Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Lifesciences Conference
Neurona Therapeutics Presents New Clinical Data from First Cohort in Ongoing Phase I/II Open-Label Trial of NRTX ...
Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days
Neurona Therapeutics Announces Presentation of Updated Clinical Data at the Upcoming American Academy of ...
Neurona raises another $120M for brain disease cell therapies
Neurona Therapeutics Completes Clinical Enrollment of First Cohort and Updates on Long-lasting Impact in First ...
